Novel T cell/organoid culture system allows

GvHD allogeneic hematopoietic stem cell transplantation alloreactive T cell epithelial cell death ex vivo model graft-versus-host disease intestinal organoids intraepithelial lymphocytes

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 05 07 2023
accepted: 14 08 2023
medline: 15 9 2023
pubmed: 14 9 2023
entrez: 14 9 2023
Statut: epublish

Résumé

Acute graft-versus-host disease (GvHD) remains the biggest clinical challenge and prognosis-determining complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Donor T cells are acceptedly key mediators of alloreactivity against host tissues and here especially the gut. In support of previous studies, we found that the intestinal intra-epithelial lymphocyte (IEL) compartment was dynamically regulated in the course of MHC class I full mismatch allo-HSCT. However, while intestinal epithelial cell (IEC) damage endangers the integrity of the intestinal barrier and is a core signature of intestinal GvHD, the question whether and to what degree IELs are contributing to IEC dysregulation is poorly understood. To study lymphoepithelial interaction, we employed a novel

Identifiants

pubmed: 37705975
doi: 10.3389/fimmu.2023.1253514
pmc: PMC10495981
doi:

Substances chimiques

Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1253514

Informations de copyright

Copyright © 2023 Matthe, Dinkel, Schmid, Vogler, Neurath, Poeck, Neufert, Büttner-Herold and Hildner.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Biol Blood Marrow Transplant. 2016 Jan;22(1):4-10
pubmed: 26386318
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Nat Rev Immunol. 2016 Feb;16(2):79-89
pubmed: 26688350
Science. 2016 Jun 24;352(6293):1581-6
pubmed: 27256884
Immunity. 2019 Jul 16;51(1):90-103.e3
pubmed: 31278057
J Gastroenterol. 2016 Mar;51(3):206-13
pubmed: 26800996
Cell Mol Immunol. 2009 Feb;6(1):15-25
pubmed: 19254476
Eur J Immunol. 1994 Mar;24(3):709-15
pubmed: 7907297
Nat Rev Immunol. 2003 Feb;3(2):147-58
pubmed: 12563298
Front Immunol. 2019 Aug 22;10:1997
pubmed: 31507601
Methods. 2017 Feb 15;115:80-90
pubmed: 27713081
Int Immunol. 1996 Nov;8(11):1767-77
pubmed: 8943572
Immunol Allergy Clin North Am. 2010 Feb;30(1):75-101
pubmed: 20113888
N Engl J Med. 2017 Nov 30;377(22):2167-2179
pubmed: 29171820
Sci Transl Med. 2021 Jan 13;13(576):
pubmed: 33441422
Sci Immunol. 2019 Dec 6;4(42):
pubmed: 31811055
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):119-127
pubmed: 27913470
J Exp Med. 1975 Jul 1;142(1):212-23
pubmed: 1056976
Front Immunol. 2021 Aug 27;12:713631
pubmed: 34512636
Mucosal Immunol. 2022 Apr;15(4):605-619
pubmed: 35654837
Eur J Immunol. 2022 Oct;52(10):1547-1560
pubmed: 35985020
Gastroenterology. 2009 Jul;137(1):15-7
pubmed: 19450592
J Exp Med. 2005 May 16;201(10):1647-57
pubmed: 15897278
Blood. 2010 Sep 9;116(10):1726-33
pubmed: 20519625
J Exp Med. 2010 Mar 15;207(3):553-64
pubmed: 20156972
Scand J Immunol. 2005 May;61(5):398-409
pubmed: 15882431
J Clin Invest. 2021 Nov 1;131(21):
pubmed: 34720090
Nat Rev Immunol. 2011 Jun 17;11(7):445-56
pubmed: 21681197
Biol Blood Marrow Transplant. 2007 Dec;13(12):1469-76
pubmed: 18022577
Nat Rev Immunol. 2007 Dec;7(12):942-53
pubmed: 18007679
Ann Hematol. 2013 Apr;92(4):497-504
pubmed: 23180439
Nat Methods. 2019 Apr;16(4):278-280
pubmed: 30886414
Biotechniques. 2019 Jul;67(1):23-28
pubmed: 31218886
JCI Insight. 2018 Sep 20;3(18):
pubmed: 30232288
Front Immunol. 2022 Nov 10;13:1008456
pubmed: 36439157
Nature. 2023 Jan;613(7945):743-750
pubmed: 36631610
Blood Adv. 2019 Nov 12;3(21):3436-3448
pubmed: 31714966
J Immunol. 2005 Dec 15;175(12):8003-10
pubmed: 16339537
Nat Rev Gastroenterol Hepatol. 2017 Dec;14(12):711-726
pubmed: 28951581
Cell Transplant. 2020 Jan-Dec;29:963689720966980
pubmed: 33073597
Nature. 2007 Oct 25;449(7165):1003-7
pubmed: 17934449
Int J Mol Sci. 2021 May 13;22(10):
pubmed: 34067987
PLoS One. 2011;6(7):e21968
pubmed: 21779359
Front Immunol. 2018 Jul 30;9:1770
pubmed: 30131803
Front Immunol. 2018 May 25;9:1138
pubmed: 29910804
Biol Blood Marrow Transplant. 2010 Sep;16(9):1309-14
pubmed: 20353832
J Immunol Methods. 2015 Jun;421:89-95
pubmed: 25841547
J Clin Invest. 2018 Mar 1;128(3):916-930
pubmed: 29376889
J Cell Biol. 2010 May 31;189(5):777-82
pubmed: 20513764
Blood. 2009 Apr 9;113(15):3612-9
pubmed: 19211507
Blood. 2020 Jun 25;135(26):2388-2401
pubmed: 32232483
J Leukoc Biol. 2021 Feb;109(2):339-347
pubmed: 32678936
Curr Transplant Rep. 2016;3(4):275-283
pubmed: 27909647
Transplantation. 1995 Jan 27;59(2):268-73
pubmed: 7839451
Nat Rev Immunol. 2018 Aug;18(8):514-525
pubmed: 29717233
Science. 1984 Jul 27;225(4660):429-30
pubmed: 6429853
Curr Opin Immunol. 1995 Jun;7(3):333-42
pubmed: 7546397
Nat Immunol. 2016 Sep 20;17(10):1235
pubmed: 27648549

Auteurs

Diana M Matthe (DM)

Department of Medicine 1, Kussmaul Campus for Medical Research, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany.

Martin Dinkel (M)

Department of Medicine 1, Kussmaul Campus for Medical Research, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany.

Benjamin Schmid (B)

Optical Imaging Centre Erlangen (OICE), University of Erlangen-Nuremberg, Erlangen, Germany.

Tina Vogler (T)

Department of Medicine 1, Kussmaul Campus for Medical Research, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany.

Markus F Neurath (MF)

Department of Medicine 1, Kussmaul Campus for Medical Research, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany.

Hendrik Poeck (H)

Clinic and Polyclinic for Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.

Clemens Neufert (C)

Department of Medicine 1, Kussmaul Campus for Medical Research, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany.

Maike Büttner-Herold (M)

Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and University Hospital, Erlangen, Germany.

Kai Hildner (K)

Department of Medicine 1, Kussmaul Campus for Medical Research, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH